人工心臓の世界市場分析:製品別(左、右、両腕補助装置)、セグメント予測

Grand View Researchが発行した調査報告書(GVIEW707877)
◆英語タイトル:Ventricular Assist Device Market Analysis by Product (Left, Right, Bi- Ventricular Assist Devices), and Segment Forecasts To 2022
◆商品コード:GVIEW707877
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2015年11月3日
◆ページ数:81
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,700 ⇒換算¥531,100見積依頼/購入/質問フォーム
Multi UserUSD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Global/corporate LicenseUSD10,500 ⇒換算¥1,186,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、人工心臓の世界市場について調査・分析し、人工心臓の世界市場動向、人工心臓の世界市場規模、市場予測、セグメント別人工心臓市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global ventricular assist device market is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology.
Furthermore, increasing healthcare expenditure, favorable reimbursement policies and advanced technological facilities, are expected to positively reinforce ventricular assist device market growth over the next seven years.

Ventricular assist device market is segmented on the basis of type of product which includes left ventricular, right ventricular and bi-ventricular assist device. Key factors attributing to rapidly increasing number of patients with end stage heart failure and low availability of therapeutic options are among the key factors attributing to the market growth.

With continual shortage of organ donors and increasing demand of LVADs’ for bridge to transplantation in patients suffering from end stage heart failure, is expected to positively reinforce market growth over the forecast period.

Lack of developed reimbursement policies in underdeveloped economies of Africa and Asia is one of the key factors attributing for low penetration of these device. However, constant economic development, improving healthcare infrastructure and reimbursement policies in countries such as India and China is expected to positively reinforce market growth in next seven years.

Technological advancements in VADs have been a continuous process since the launch of first generation device. First generation VADs are referred to as pulsatile volume displacement pumps which are powered by pneumatic or electrical drive systems. Some of the U.S. FDA approved products are the Abiomed BVS5000, Worldheart Novacor System (LVAS).

Second generation ventricular assist device which are usually known as continuous flow LVADs were developed to overcome several limitations of the pulsatile displacement systems. At present, second generation LVADs that are available include the TandemHeart pVAD, Thoratec Heartmate II, Jarvik 2000, and the Impella Pump System.

Third generation ventricular assist device such as VentrAssist, DuraHeart, HeartMate III LVAD and others are currently under various stages of development, clinical trials and commercialization stages. These third generation ventricular assist device are continuous flow device with more advancement in product design, materials, battery capacity and size. Constant development in these devices serves as a high impact rendering driver for the growth of the market.

Further key findings from the report suggest:

In 2014, North America accounted for largest market share of over55%. Key factors attributing to its large share include presence of advanced healthcare infrastructure, and high level of collaboration between various stakeholders including medical fraternity, medical device industry, regulatory authorities, universities and others.
Furthermore, presence of high research expenditure by public and private entities in healthcare sector is anticipated to propel market growth for ventricular assist device in the coming seven years.
Asia Pacific is expected to be one of the fastest growing markets, growing at a CAGR of over17% during the forecast period. Key factors attributed to the growth are high economic growth in countries such as China, Brazil, India, and South Korea coupled with high unmet medical needs is expected to boost usage rates of ventricular assist device.
Key players operating in ventricular assist device market include Abiomed, HeartWare International, Thoratec, Inc., Berlin Heart, Cardiac Assist and ReliantHeart

【レポートの目次】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Ventricular Assist device– Industry Snapshot and Key Buying Criteria, 2012 – 2022
Chapter 3. Ventricular assist device Industry Outlook
3.1. Ventricular assist device market segmentation
3.2. Ventricular assist device market size and growth prospects
3.3. Ventricular assist device Market dynamics
3.4. Market driver analysis
3.5. Market restraint analysis
3.6. Key opportunities prioritized
3.7. Industry analysis – Porter’s
3.8. Ventricular assist device technology trend analysis
3.9. Company market share analysis, 2014
3.10. Ventricular assist device: PESTEL analysis, 2014
Chapter 4. Ventricular Assist device Product Outlook
4.1. Ventricular assist device market share, by product, 2014 & 2022
4.2. Left ventricular assist device
4.2.1. Left ventricular assist device market estimates and forecasts, 2012 – 2022 (USD Million)
4.3. Right ventricular assist device
4.3.1. Right ventricular assist device market estimates and forecasts, 2012 – 2022 (USD Million)
4.4. Bi-ventricular assist device
4.4.1. Bi-ventricular assist device market estimates and forecasts, 2012 – 2022 (USD Million)
Chapter 5. Ventricular Assist device Regional Outlook
5.1. Ventricular assist device market share, by region, 2014 & 2022
5.2. North America
5.2.1. North America ventricular assist device market estimates and forecasts, by product, 2012 – 2022
5.2.1.1. U.S. ventricular assist device market estimates and forecasts, 2012 – 2022
5.2.1.2. Canada ventricular assist device market estimates and forecasts, 2012 – 2022
5.3. Europe
5.3.1. Europe ventricular assist device market estimates and forecasts, by product, 2012 – 2022
5.3.1.1. UK ventricular assist device market estimates and forecasts, 2012 – 2022
5.3.1.2. Germany ventricular assist device market estimates and forecasts, 2012 – 2022
5.4. Asia Pacific
5.4.1. Asia Pacific ventricular assist device market estimates and forecasts, by product, 2012 – 2022
5.4.1.1. Japan ventricular assist device market estimates and forecasts, 2012 – 2022
5.4.1.2. China ventricular assist device market estimates and forecasts, 2012 – 2022
5.4.1.3. India ventricular assist device market estimates and forecasts, 2012 – 2022
5.5. Latin America
5.5.1. Latin America ventricular assist device market estimates and forecasts, by product, 2012 – 2022
5.5.1.1. Brazil ventricular assist device market estimates and forecasts, 2012 – 2022
5.5.1.2. Mexico ventricular assist device market estimates and forecasts, 2012 – 2022
5.6. MEA
5.6.1. MEA ventricular assist device market estimates and forecasts, by product, 2012 – 2022
5.6.1.1. South Africa ventricular assist device market estimates and forecasts, 2012 – 2022
Chapter 6. Competitive Landscape
6.1. Abiomed
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. HeartWare International
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Thoratec
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Berlin Heart
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Cardiac Assist
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Jarvik Heart
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Reliantheart
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Sun Medical Technology Research
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 人工心臓の世界市場分析:製品別(左、右、両腕補助装置)、セグメント予測(Ventricular Assist Device Market Analysis by Product (Left, Right, Bi- Ventricular Assist Devices), and Segment Forecasts To 2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆